Driving Regenerative Medicine to the Market and Clinic: An Exploration of Enablers, Impediments and Ethical-Legal Challenges
This series of articles investigates a broad range of legal, management, ethical, economic, and social issues associated with the translation and commercialization of regenerative medicine technologies and services. Articles published in this series were invited from delegates that attended Driving Regenerative Medicine to the Market and Clinic: An Exploration of Enablers, Impediments and Ethical-Legal Challenges, held In Toronto, ON, November 5-7, 2014. The organizers would like to thank the Stem Cell Network, the Cancer Stem Cell Consortium, Genome Canada, Genome Quebec, Genome Alberta, the Ontario Genomics Institute, the Canadian Institutes for Health Research, and Alberta Innovates-Health Solutions for their generous support of both this event.
All articles have been independently prepared by the authors and have been subject to the standard peer review processes of the journals.